FDA, Advocacy Group Clash Over Hydroxychloroquine
As the debate on hydroxychloroquine rages on, the FDA and a new advocacy group have sparred about the appropriateness of physicians prescribing the drug for COVID-19.
When the Cytokine Storm Hits COVID-19 Patients
A New York City cardiologist talks about the presentation of patients with severe COVID-19 who experienced this condition.
Panel Gives Weak Recommendation for Remdesivir for Severe COVID-19 Patients
After review of 2 randomized trials, a panel of health care providers and patients see limited benefit for the medication.
Lilly, NIAID Launch Phase 3 Prevention Trial Centered on Nursing Homes
The trial will assess a monoclonal antibody based investigational treatment that may prevent COVID-19.
RLF-100 Could Reduce Ventilator Use, Viral Replication in Severe COVID-19
The VIP antiviral therapy shows capability in reducing COVID-19 inflammatory biomarkers, as well as respiratory failure risks.
Technique Predicts Stability of Potential Monoclonal Antibody Therapies
Collodial stability measures may predict whether a potential antibody-based treatment will work early on in the drug development process.
Keeping up with Patient Care During the COVID-19 Quarantine
Medha Munshi, MD, discusses the specific challenges of the quarantine and how she was able to help her patients with diabetes comply with their care.
Influenza Vaccines Are Being Shipped
Manufacturers announce their supplies are being sent out for the upcoming season.
Key FDA Diagnostic Authorizations of the Week
Since the emergence of the SARS-CoV-2 pandemic in particular, news in the infectious disease drug and medical device pipeline has moved at an accelerated pace.
FDA Adds More Toxic Sanitizer to Recall List
Broncolin S.A. de C.V is voluntarily recalling all lots of Herbacil Antiseptic Hand Sanitizer 70% Alcohol to the consumer level. The products are being recalled due to the potential presence of methanol (wood alcohol).
Healthcare Worker COVID-19 Risk Linked to Ethnicity, PPE, and Case Exposure
New findings show "structural inequities" among the US and UK frontline responders first infected months ago.
Fauci Testifies on Unifying Coronavirus Response at Hearing
Dr. Anthony Fauci, CDC's Dr. Robert Redfield, & HHS' Admiral Brett Giroir spoke at a congressional hearing on coordinating the future of the national coronavirus response.
2 Companies Supplying US with 100 Million Doses of COVID-19 Vaccine
GSK, Sanofi were selected by US Operation Warp Speed to provide a large supply.
Vaccine Experts Sound Off On Current COVID-19 Developments
A look at the history of vaccines, our society's current standing in public health and vaccine preparedness, and what may come in the near future.
Does Data Improve Vaccine Adherence?
What role does new research play in combating public vaccination concerns?
Dr. Peter Hotez Argues for Federal Coordination of COVID-19 Response
Peter Hotez, MD, PhD, recently authored a paper proposing a federally directed but state-adaptive reopening that aims for acceptable national suppression by October 1.
Organizations Ask People with HIV be Included in Vaccine Research
IDSA, HIVMA request they be included in ongoing COVID-19 clinical trials.
How Are Vaccines Deemed Safe?
A discussion on the process by which the FDA regulates vaccine candidates at a time when COVID-19 candidates are progressing.
The COVID-19 Live Vaccine Tracker
Here is a compilation of the COVID-19 vaccine candidates that have achieved FDA Emergency Use Authorization, other approvals, and are in phases 1-3.
Dual Anti-Viral/Anti-Inflammatory Drug Study Against COVID-19 Begins
RedHill Biopharma has initiated a global phase 2/3 study in order to evaluate the use of opaganib in patients with severe COVID-19.
Herman Cain Passes After 3-Week Coronavirus Battle
On Tuesday, Cain was said to be recovering, possibly reflecting the complex immune system stages of COVID-19 disease course.
Coronavirus Science Is Not Binary
Why reducing pandemic research and response to yes-or-no outcomes is harming public health.
Webinar: Race for a COVID-19 Vaccine
MJH Life Sciences is presenting a webinar today on this important topic.
Early COVID-19 Cases Linked to China, Italy, Iran
People with travel links to China, Iran, and Italy may have accounted for nearly two-thirds of early COVID-19 cases in affected countries.
Quest: FDA Authorization Could Raise Daily Test Capacity by 35000
The method extracts SARS-CoV-2 RNA with the Mag-Bind Viral RNA Xpress Kit and the Hamilton MagEx STAR.
Connecting COVID-19 to Cancer Research
Dr. Adam Brufsky, an oncologist, compares viral and cancer immunity. Dr. Patrick Soon-Shiong connects the relation to COVID-19 vaccine research.
Setting Standards for a COVID-19 Vaccine
What should be anticipated in effectiveness and implication for the leading candidates.
RA Therapy Studied for COVID-19 Does Not Meet Endpoint
Roche’s tocilizumab did not improve clinical status in hospitalized adult patients with severe COVID-19 associated pneumonia.
Ebola Survivors Face Stigma, Reproductive Health Impact
Infectious disease specialists explain how long term international cooperation with impacted societies can help to stop the cycle of Ebola outbreaks.
Age-Related Comorbidities for Patients Living with HIV
Nearly half of all the people living with HIV are over the age of 50, so age-related comorbidities are becoming a factor.
